<p>Median values for the relative variable importance and interquartile ranges are shown for all antigens tested: SERA3 ag 1 (4.8%; IQR 2.5–7.8%); SERA3 ag 2 (50.4%; IQR 43.3–61.4%); <i>Pk</i>SSP2/TRAP (6.5%; IQR 3.7–11.8%) and TSERA ag 1 (34.2%; IQR 26.2–41.8%).</p
<p>The prognostic value of cytokine levels measured at inclusion was evaluated by stepwise multivari...
<p>Age-adjusted seroprevalence (blue solid lines) using appropriate reversible catalytic models. The...
<p>A: cumulative incidence (total number of symptomatic cases) over a 28-year simulation as a functi...
<p>(comparison of <i>P</i>. <i>knowlesi</i> exposed individuals with non-exposed individuals).</p
<p>In each model, magnitude = total beneficial response (sum of responses to beneficial peptide pool...
<p>Comparison of our parameter estimates and previously published estimates of <i>R</i>, from studie...
<p>The chart shows the combined effects of independent risk on the estimated prevalence of leptospir...
<p>(a) SERA3 ag1, (b) SERA3 ag2, (c) SSP2/TRAP and (d) TSERA2 ag1. Asterisks indicate level of signi...
Results from a log-binomial regression model of seroprevalence to long-term antigens (AMA-1, GLURP-R...
<p>Results of a logistic regression model showing the effect of red cell blood group antigens on HIV...
<p>Results of univariate and multivariate regression models predicting factors associated with HIV-p...
<p>(comparison of <i>P</i>. <i>knowlesi</i> exposed individuals with individuals exposed to other no...
<p>(A) The levels of various cytokines in the serum of subjects, measured by multiplex bead assay, a...
<p>The number of IgE reactive subjects and the Pearson coefficient are shown for paired allergens wi...
(A, B) Average frequencies of T cell responses to each of the antigens in cohort 1 (A) or cohort 2 (...
<p>The prognostic value of cytokine levels measured at inclusion was evaluated by stepwise multivari...
<p>Age-adjusted seroprevalence (blue solid lines) using appropriate reversible catalytic models. The...
<p>A: cumulative incidence (total number of symptomatic cases) over a 28-year simulation as a functi...
<p>(comparison of <i>P</i>. <i>knowlesi</i> exposed individuals with non-exposed individuals).</p
<p>In each model, magnitude = total beneficial response (sum of responses to beneficial peptide pool...
<p>Comparison of our parameter estimates and previously published estimates of <i>R</i>, from studie...
<p>The chart shows the combined effects of independent risk on the estimated prevalence of leptospir...
<p>(a) SERA3 ag1, (b) SERA3 ag2, (c) SSP2/TRAP and (d) TSERA2 ag1. Asterisks indicate level of signi...
Results from a log-binomial regression model of seroprevalence to long-term antigens (AMA-1, GLURP-R...
<p>Results of a logistic regression model showing the effect of red cell blood group antigens on HIV...
<p>Results of univariate and multivariate regression models predicting factors associated with HIV-p...
<p>(comparison of <i>P</i>. <i>knowlesi</i> exposed individuals with individuals exposed to other no...
<p>(A) The levels of various cytokines in the serum of subjects, measured by multiplex bead assay, a...
<p>The number of IgE reactive subjects and the Pearson coefficient are shown for paired allergens wi...
(A, B) Average frequencies of T cell responses to each of the antigens in cohort 1 (A) or cohort 2 (...
<p>The prognostic value of cytokine levels measured at inclusion was evaluated by stepwise multivari...
<p>Age-adjusted seroprevalence (blue solid lines) using appropriate reversible catalytic models. The...
<p>A: cumulative incidence (total number of symptomatic cases) over a 28-year simulation as a functi...